Marinus Pharmaceuticals | MRNS

Marinus Pharmaceuticals traded at $6.18 this Thursday March 23rd, increasing $0.18 or 3.00 percent since the previous trading session. Looking back, over the last four weeks, Marinus Pharmaceuticals gained 3.44 percent. Over the last 12 months, its price fell by 39.82 percent. Looking ahead, we forecast Marinus Pharmaceuticals to be priced at 6.57 by the end of this quarter and at 5.97 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Eisai 7,151.00 -38.00 -0.53% 19.84%
Acadia Pharmaceuticals 18.32 -0.18 -0.97% -32.52%
ALKERMES 25.75 -0.08 -0.31% -3.09%
Amgen 233.10 3.27 1.42% -1.59%
Aptinyx Inc 0.18 0.04 24.49% -93.51%
Biogen 265.17 3.95 1.51% 24.49%
Enanta Pharmaceuticals 39.60 -0.09 -0.23% -41.57%
Esperion Therapeutics 1.56 0.10 6.85% -69.41%
Gilead Sciences 78.76 0.95 1.22% 33.70%
Intercept Pharmaceuticals 13.69 0.10 0.74% -18.80%
Incyte Corp 72.26 0 0% -7.58%
Intra Cellular Therapies 45.89 0.28 0.61% -22.73%
Marinus Pharmaceuticals 6.18 0.18 3.00% -39.82%
Neurocrine Biosciences 95.69 0.54 0.57% 1.74%
Minerva Neurosciences 1.65 -0.05 -2.98% 105.79%
PTC Therapeutics 46.67 0.32 0.69% 24.65%
Regeneron Pharmaceuticals 802.16 50.86 6.77% 17.96%
Sarepta Therapeutics 128.38 -0.73 -0.57% 59.60%
Supernus Pharmaceuticals 35.00 -0.36 -1.02% 8.46%
UCB 78.58 0.34 0.43% -27.11%
Vertex Pharmaceuticals 304.75 6.88 2.31% 20.00%

Indexes Price Day Year
USND 11787 117.44 1.01% -16.94%

Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc is a United States-based biopharmaceutical company. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post-traumatic stress, and fragile-x syndrome. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings.